Study of Cabiralizumab in Combination With Nivolumab in Patients With Selected Advanced Cancers
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Nivolumab
Related studies linked through entity extraction aliases.
ALT-803 Plus Nivolumab in Patients With Pretreated, Advanced or Metastatic Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Neoadjuvant and Adjuvant Checkpoint Blockade
- Status
- COMPLETED
- Phase
- PHASE2
A Phase I, Open-Label, Multiple Ascending Dose Study of RRx-001 and Nivolumab
- Status
- COMPLETED
- Phase
- PHASE1
Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Sarcoma That Cannot Be Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE2
Nivolumab After Induction Treatment in Triple-negative Breast Cancer (TNBC) Patients
- Status
- UNKNOWN
- Phase
- PHASE2
Nivolumab With or Without Ipilimumab in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Nivolumab in Patients With Recurrent Malignant Mesothelioma
- Status
- COMPLETED
- Phase
- PHASE2
Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
An Investigational Immuno-therapy Study to Investigate the Safety and Effectiveness of Nivolumab, and Nivolumab Combination Therapy in Virus-associated Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of BBI503 in Combination With Selected Anti-Cancer Therapeutics in Adult Patients With Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Effectiveness Study of Nivolumab Compared to Chemotherapy in Patients With Relapsed Small-cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE3
An Investigational Immuno-therapy Trial of Nivolumab, or Nivolumab Plus Ipilimumab, or Nivolumab Plus Platinum-doublet Chemotherapy, Compared to Platinum Doublet Chemotherapy in Patients With Stage IV Non-Small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE3
Expanded Access Program With Nivolumab Therapy for Treatment of Advanced/Metastatic SqNSCLC or Non-SqNSCLC After One Prior Systemic Regimen
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Safety and Efficacy Study of Ulocuplumab and Nivolumab in Subjects With Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study of BBI608 Administered in Combination With Immune Checkpoint Inhibitors in Adult Patients With Advanced Cancers
- Status
- COMPLETED
- Phase
- PHASE1
Study of Nivolumab in Combination With GM.CD40L Vaccine in Adenocarcinoma of the Lung
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of Idarubicin, Cytarabine, and Nivolumab in Patients With High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Entinostat, Nivolumab, and Ipilimumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Locally Advanced or Metastatic HER2-Negative Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1